Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
IGF-DES shares the mitotic risks of all IGF-1 analogs but has a distinct metabolic safety profile due to its short half-life
IGF-1 and its modified synthetic versions such as Long R3 IGF-1, des(1-3)IGF-1, and R3-IGF-I, have mitogenic effects, which speed up cell replication in laboratory models of different tissues
Begin by reducing ongoing exposure, reviewing medications and alcohol, confirming liver and kidney safety, restoring adequate protein and nutrients, supporting bowel elimination and treating confirmed methylation, gut or biliary abnormalities
Over-the-counter products simply cant match the potency or clinical research behind medical-grade formulations
Begin within days of surgery continuing through rehabilitation phase (3-6 months typically)
Funded by the South African Medical Research Council
US$ 21.42
US$ 26.22
US$ 28.97
